Literature DB >> 1821296

Effects of nicotine gum on prevalence and severity of withdrawal in female cigarette smokers.

D Hatsukami1, C McBride, P Pirie, W Hellerstedt, H Lando.   

Abstract

This study examines the extent to which 2 mg nicotine gum reduces the prevalence and severity of cigarette withdrawal signs and symptoms. The sample was comprised of women who were randomly assigned to chew 2 mg nicotine gum (N = 206) or no nicotine gum (N = 211). Signs and symptoms of withdrawal were assessed at days 2, 7, 14, and 28 post-cessation. The results showed a significant effect of 2 mg nicotine compared to no gum at 2 days post-cessation on the prevalence of the following symptoms: anxious/tense, difficulty concentrating, restless, impatient, somatic symptoms, insomnia, increased eating, and drowsiness. There were additional differences between the two groups for the severity of craving for cigarettes, irritable/angry, excessive hunger, and total withdrawal score. Over the course of 28 days post-cessation, significant Group and/or Group x Time interaction effects were found with regard to the severity of signs and symptoms for the following variables: impatient, insomnia, increased eating, irritable, difficulty concentrating, restless, somatic complaints, and total withdrawal score. These results are similar to those obtained from placebo-controlled trials for nicotine gum.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1821296     DOI: 10.1016/s0899-3289(10)80024-0

Source DB:  PubMed          Journal:  J Subst Abuse        ISSN: 0899-3289


  6 in total

1.  Severity of tobacco abstinence symptoms varies by time of day.

Authors:  Kenneth A Perkins; Jessica Briski; Carolyn Fonte; John Scott; Caryn Lerman
Journal:  Nicotine Tob Res       Date:  2009-01-27       Impact factor: 4.244

2.  A single administration of low-dose varenicline saturates α4β2* nicotinic acetylcholine receptors in the human brain.

Authors:  Shahrdad Lotfipour; Mark Mandelkern; Miguel Alvarez-Estrada; Arthur L Brody
Journal:  Neuropsychopharmacology       Date:  2012-03-07       Impact factor: 7.853

3.  Dependence on tobacco and nicotine products: a case for product-specific assessment.

Authors:  Karl Fagerström; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2012-03-29       Impact factor: 4.244

4.  Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.

Authors:  Michael Kotlyar; Louise A Hertsgaard; Bruce R Lindgren; Joni A Jensen; Steven G Carmella; Irina Stepanov; Sharon E Murphy; Stephen S Hecht; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-10       Impact factor: 4.254

5.  Reduced nicotine content cigarettes and nicotine patch.

Authors:  Dorothy K Hatsukami; Louise A Hertsgaard; Rachel I Vogel; Joni A Jensen; Sharon E Murphy; Stephen S Hecht; Steven G Carmella; Mustafa al'Absi; Anne M Joseph; Sharon S Allen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-19       Impact factor: 4.254

6.  Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.

Authors:  Dorothy K Hatsukami; Michael Kotlyar; Louise A Hertsgaard; Yan Zhang; Steven G Carmella; Joni A Jensen; Sharon S Allen; Peter G Shields; Sharon E Murphy; Irina Stepanov; Stephen S Hecht
Journal:  Addiction       Date:  2010-02       Impact factor: 6.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.